<DOC>
	<DOC>NCT00563160</DOC>
	<brief_summary>To study the activity of chemotherapy with Gemzar-carboplatin in the preoperative setting for operable stages of non-small-cell lung cancer and to identify novel molecular markers correlated with chemosensitivity and prognosis</brief_summary>
	<brief_title>Study of Efficacy of Induction Chemotherapy With Gemcitabine and Carboplatin for Operable Non-small-cell Lung Cancer Before Surgery</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>Histologically or cytologically proven, newly diagnosed primary bronchogenic nonsmall cell lung cancer Measurable or evaluable tumour on chest Xray or CT scan. No multiple ipsilateral or contralateral parenchymal tumours Stage I(exceptT1N0),II,IIIa disease as shown by PETCT</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>lung cancer</keyword>
</DOC>